Wantai BioPharm to revamp governance, elect new board member

Beijing Wantai Biological Pharmacy Enterprise will hold its second extraordinary general meeting of shareholders in 2025 on November 28, 2025. Shareholders will consider proposals to abolish the supervisory board and amend the company's articles of association, with the audit committee taking over the supervisory board's functions. The meeting will also review revisions to related governance documents, including the "Related Party Transaction Management System," "Board of Directors Rules of Procedure," "Shareholders Meeting Rules of Procedure," "Independent Directors Work System," and "Cumulative Voting Implementation Rules."

The meeting will use a combination of on-site and online voting through the Shanghai Stock Exchange's online voting system. Online voting will be open from 9:15 to 15:00 on November 28, 2025.

Additionally, shareholders will vote on the election of Lu Yun as a non-independent director for the sixth session of the board of directors. Lu Yun, born in 1989, is a Chinese Certified Public Accountant and has served as the company's chief financial officer since April 2024. He does not hold any company shares and has no related party connections with directors, supervisors, senior management, actual controllers, or shareholders holding more than 5% of the company's shares.